Search research articles
Contact Us
Filters
Showing results (41-50 of 45) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 45 results.
Oncogene
|
September 5, 2017
Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment
M R Heerma van Voss, F Vesuna, G M Bol, et al.
Prostate Cancer and Prostatic Diseases
|
May 4, 2016
Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk
A E Ross, R B Den, K Yousefi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 10, 2023
Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer
P A Sutera, A C Shetty, A Hakansson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 6, 2026
Multimodal Artificial Intelligence Prediction of Abiraterone Efficacy in Two STAMPEDE Phase 3 Trials of Non-Metastatic Very High-Risk Prostate Cancer
C T A Parker, H-C Huang, E Grist, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 22, 2025
Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials
A Dal Pra, P Ghadjar, H M Ryu, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 45) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 45 results.
Oncogene
|
September 5, 2017
Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment
M R Heerma van Voss, F Vesuna, G M Bol, et al.
Prostate Cancer and Prostatic Diseases
|
May 4, 2016
Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk
A E Ross, R B Den, K Yousefi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 10, 2023
Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer
P A Sutera, A C Shetty, A Hakansson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 6, 2026
Multimodal Artificial Intelligence Prediction of Abiraterone Efficacy in Two STAMPEDE Phase 3 Trials of Non-Metastatic Very High-Risk Prostate Cancer
C T A Parker, H-C Huang, E Grist, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 22, 2025
Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials
A Dal Pra, P Ghadjar, H M Ryu, et al.
Page
of 5